# EDGAR Filing Document

**Accession Number:** 0001606757
**File Stem:** 0001606757-23-000005
**Filing Date:** 2023-2
**Character Count:** 28567
**Document Hash:** 8e47c30f1d1fe2b54f150284873e154c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001606757-23-000005.hdr.sgml**: 20230206

**ACCESSION NUMBER**: 0001606757-23-000005

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20230206

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230206

**DATE AS OF CHANGE**: 20230206

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Kimball Electronics, Inc.
- **CENTRAL INDEX KEY:** 0001606757
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRINTED CIRCUIT BOARDS [3672]
- **IRS NUMBER:** 352047713
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36454
- **FILM NUMBER:** 23591024

**BUSINESS ADDRESS:**
- **STREET 1:** 1205 KIMBALL BLVD.
- **CITY:** JASPER
- **STATE:** IN
- **ZIP:** 47546
- **BUSINESS PHONE:** 812-634-4000

**MAIL ADDRESS:**
- **STREET 1:** 1205 KIMBALL BLVD.
- **CITY:** JASPER
- **STATE:** IN
- **ZIP:** 47546

?xml version="1.0" ? ke-20230206

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported) February 6, 2023

![ke-20230206_g1.jpg](ke-20230206_g1.jpg)

**KIMBALL ELECTRONICS, INC.**

**________________________________________________________________________________________________________**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Indiana | 001-36454 | 35-2047713 |
| (State or other jurisdiction of | (Commission File | (IRS Employer Identification No.) |
| incorporation) | Number) | |

---

---

| | |
|:---|:---|
| 1205 Kimball Boulevard, Jasper, Indiana | 47546 |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code <u>(812) 634-4000</u>

Not Applicable <br> (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** |
| **<u>Title of each Class</u>** | **<u>Trading Symbol</u>** | **<u>Name of each exchange on which registered</u>** |
| Common Stock, no par value | KE | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 Results of Operations and Financial Condition**

On February 6, 2023, the Company issued an earnings release for the second quarter ended December 31, 2022. The earnings release is attached as Exhibit 99.1.

The information in Item 2.02 of this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended, except as shall otherwise be expressly set forth by specific reference in such filing.

**Item 9.01 Financial Statements and Exhibits**

**(d) Exhibits**

---

| | |
|:---|:---|
| Exhibit |  |
| <u>Number</u> | <u>Description</u> |
| 99.1 | <u>[Earnings Release dated February 6, 2023](exhibit9918k12312022q210q.htm)</u> |
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| | KIMBALL ELECTRONICS, INC. |
| By: | /s/ Jana T. Croom |
|  | JANA T. CROOM<br>Chief Financial Officer |

---

Date: February 6, 2023

## Exhibit 99.1

**Exhibit 99.1**

**KIMBALL ELECTRONICS REPORTS Q2 RESULTS WITH RECORD SALES AND EXPANDING OPERATING MARGIN; COMPANY RAISES OUTLOOK FOR TOP-LINE GROWTH IN FISCAL YEAR 2023**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net sales in the second quarter of fiscal 2023 totaled $436.7 million, an all-time quarterly high and up 39% year-over-year; foreign currency had a 5% unfavorable impact on net sales compared to the second quarter of fiscal 2022

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Operating income of $17.5 million, or 4.0% of net sales, compared to operating income of $6.9 million, or 2.2% of net sales in the same period last year

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income of $10.7 million, or $0.43 per diluted share, compared to net income of $5.1 million, or $0.20 per diluted share, in the second quarter of fiscal 2022

JASPER, Ind., February 6, 2023 -- (BUSINESS WIRE) -- Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for the second quarter ended December 31, 2022.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| (Amounts in Thousands, except EPS) | **2022** | **2021** | **2022** | **2021** |
| Net Sales | $436696 | $315264 | $842585 | $607981 |
| Operating Income | $17489 | $6914 | $31060 | $11694 |
| Adjusted Operating Income (non-GAAP) <sup>(1)</sup> | $17829 | $7316 | $31165 | $10625 |
| Operating Income % | 4.0% | 2.2% | 3.7% | 1.9% |
| Adjusted Operating Income (non-GAAP) % | 4.1% | 2.3% | 3.7% | 1.7% |
| Net Income | $10720 | $5113 | $20229 | $7677 |
| Adjusted Net Income (non-GAAP) <sup>(1)</sup> | $10999 | $5113 | $20508 | $6627 |
| Diluted EPS | $0.43 | $0.20 | $0.81 | $0.30 |
| Adjusted Diluted EPS (non-GAAP) <sup>(1)</sup> | $0.44 | $0.20 | $0.82 | $0.26 |

---

*(1) A reconciliation of GAAP and non-GAAP financial measures is included below.* 

Donald D. Charron, Chairman and Chief Executive Officer, stated, "I am very pleased with our results in Q2. For the fourth consecutive quarter, net sales were at an all-time high for the Company, and operating margin expanded both sequentially and compared to the same period last year. Our team continues to ramp-up production on new and existing programs, leverage our facility expansions in Thailand and Mexico, and begin to work down the backlog of open orders resulting from pandemic-related global supply chain disruptions and component part shortages. We expect improvement in sales and margin to continue for the balance of the year, as part of a stair-stepped fiscal 2023, and we are raising our outlook for full year sales, and expect operating margin to be in the mid-to-upper end of the guidance range."

Mr. Charron continued, "As previously announced, I will be retiring at the end of February, so this will be my last earnings release as Chairman and CEO of Kimball Electronics. It is with immense gratitude and pride that I say farewell, and thank you. I have been very fortunate throughout my career, and I'm confident our global enterprise, exceptional leadership team, and impressive incoming CEO, Ric Phillips, will build on our legacy of award-winning service to customers, the communities where we operate, and Share Owners. I have never been more excited about the future of Kimball Electronics."

As part of today's announcement, the Company raised its guidance for net sales in fiscal 2023 to a range of $1.7 - $1.8 billion, a 26% - 33% increase compared to the prior year. As a reminder, the original guidance for net sales was in the range of $1.6 - $1.7 billion. Operating margin is expected to be at the mid-to-upper end of the guidance range of 4.6% - 5.2% of net sales, and capital expenditures are expected to be in the range of $80 - $100 million.

------

Second Quarter Fiscal 2023 Overview

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash flow used by operating activities of $11.7 million during the second quarter of fiscal 2023

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash conversion days ("CCD") for the quarter ended December 31, 2022 were 103 days, up from 99 days in the first quarter of fiscal year 2023; CCD is calculated as the sum of days sales outstanding plus contract asset days plus production days supply on hand less accounts payable days

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Investments in capital expenditures were $22.7 million during the quarter

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash and cash equivalents of $26.3 million and borrowings outstanding on credit facilities of $273.5 million at December 31, 2022, including $235.0 million classified as long term

Net Sales by Vertical Market for Q2 Fiscal 2023:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** | | **December 31,** | **December 31,** | **December 31,** | **December 31,** | |
| (Amounts in Millions) | **2022** | \* | **2021** | \* | **Percent Change** | **2022** | \* | **2021** | \* | **Percent Change** |
| Automotive | $200.0 | 46% | $139.0 | 44% | 44% | $384.5 | 46% | $268.4 | 44% | 43% |
| Medical | 124.7 | 29% | 89.8 | 29% | 39% | 239.5 | 28% | 174.8 | 29% | 37% |
| Industrial <sup>(1)</sup> | 105.0 | 24% | 82.6 | 26% | 27% | 205.9 | 24% | 157.6 | 26% | 31% |
| Other | 7.0 | 1% | 3.9 | 1% | 77% | 12.7 | 2% | 7.2 | 1% | 76% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Net Sales | $436.7 |  | $315.3 |  | 39% | $842.6 |  | $608.0 |  | 39% |
| &nbsp;&nbsp;&nbsp;*\*As a percent of Total Net Sales* | &nbsp;&nbsp;&nbsp;*\*As a percent of Total Net Sales* | &nbsp;&nbsp;&nbsp;*\*As a percent of Total Net Sales* | &nbsp;&nbsp;&nbsp;*\*As a percent of Total Net Sales* | &nbsp;&nbsp;&nbsp;*\*As a percent of Total Net Sales* | &nbsp;&nbsp;&nbsp;*\*As a percent of Total Net Sales* |  |  |  |  |  |
| &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* | &nbsp;&nbsp;*(1) Beginning in fiscal year 2023, Public Safety was combined with Industrial; all prior periods have been recast to conform to current period presentation* |
| &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* | &nbsp;&nbsp;&nbsp;*–Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems* |
| &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* | &nbsp;&nbsp;&nbsp;*–Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring* |
| &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* | &nbsp;&nbsp;&nbsp;*–Industrial includes climate controls, automation controls, optical inspection, smart metering, and public safety* |

---

------

**<u>Forward-Looking Statements</u>**

Certain statements contained within this release are considered forward-looking, including our fiscal year 2023 guidance, under the Private Securities Litigation Reform Act of 1995. The statements may be identified by the use of words such as "expect," "should," "goal," "predict," "will," "future," "optimistic," "confident," and "believe." Undue reliance should not be placed on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. These forward-looking statements are subject to risks and uncertainties including, without limitation, global economic conditions, geopolitical environment and conflicts such as the war in Ukraine, global health emergencies including the COVID-19 pandemic, availability or cost of raw materials and components, foreign exchange rate fluctuations, and our ability to convert new business opportunities into customers and revenue. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of the company are contained in its Annual Report on Form 10-K for the year ended June 30, 2022.

**<u>Non-GAAP Financial Measures</u>**

This press release contains non-GAAP financial measures. The non-GAAP financial measures contained herein include adjusted operating income, adjusted net income, adjusted diluted EPS, and ROIC. Reconciliations of the reported GAAP numbers to these non-GAAP financial measures are included in the Reconciliation of Non-GAAP Financial Measures section below. Management believes these measures are useful and allow investors to meaningfully trend, analyze, and benchmark the performance of the company's core operations. The company's non-GAAP financial measures are not necessarily comparable to non-GAAP information used by other companies.

**<u>About Kimball Electronics, Inc.</u>**

Kimball Electronics is a multifaceted manufacturing solutions provider of electronics and diversified contract manufacturing services to customers around the world. From our operations in the United States, China, India, Japan, Mexico, Poland, Romania, Thailand, and Vietnam, our teams are proud to provide manufacturing services for a variety of industries. Recognized for a reputation of excellence, we are committed to a high-performance culture that values personal and organizational commitment to quality, reliability, value, speed, and ethical behavior. Kimball Electronics, Inc. (Nasdaq: KE) is headquartered in Jasper, Indiana.

To learn more about Kimball Electronics, visit: www.kimballelectronics.com.

---

| | |
|:---|:---|
| **<u>Conference Call / Webcast</u>** | **<u>Conference Call / Webcast</u>** |
| Date: | February 7, 2023 |
| Time: | 10:00 AM Eastern Time |
| Live Webcast: | investors.kimballelectronics.com/events-and-presentations/events |
| Dial-In #: | 844-200-6205 (other locations - 929-526-1599) |
| Conference ID: | 914955 |

---

For those unable to participate in the live webcast, the call will be archived at investors.kimballelectronics.com.

**Lasting relationships. Global success.**

------

Financial highlights for the second quarter and year-to-date period ended December 31, 2022 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Condensed Consolidated Statements of Income** | **Condensed Consolidated Statements of Income** | | | |
| (Unaudited) | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| (Amounts in Thousands, except Per Share Data) | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** |
| Net Sales | $436696 | 100.0% | $315264 | 100.0% |
| Cost of Sales | 402505 | 92.2% | 294427 | 93.4% |
| Gross Profit | 34191 | 7.8% | 20837 | 6.6% |
| Selling and Administrative Expenses | 16702 | 3.8% | 13923 | 4.4% |
| Operating Income | 17489 | 4.0% | 6914 | 2.2% |
| Other Income (Expense), net | (3296) | (0.7)% | (209) | (0.1)% |
| Income Before Taxes on Income | 14193 | 3.3% | 6705 | 2.1% |
| Provision for Income Taxes | 3473 | 0.8% | 1592 | 0.5% |
| Net Income | $10720 | 2.5% | $5113 | 1.6% |
| Earnings Per Share of Common Stock: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.43 |  | $0.20 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.43 |  | $0.20 |  |
| Average Number of Shares Outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic | 24881 |  | 25238 |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted | 25000 |  | 25282 |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| (Unaudited) | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| (Amounts in Thousands, except Per Share Data) | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** |
| Net Sales | $842585 | 100.0% | $607981 | 100.0% |
| Cost of Sales | 779073 | 92.5% | 571544 | 94.0% |
| Gross Profit | 63512 | 7.5% | 36437 | 6.0% |
| Selling and Administrative Expenses | 32452 | 3.8% | 26127 | 4.3% |
| Other General Expense (Income) |  | —% | (1384) | (0.2)% |
| Operating Income | 31060 | 3.7% | 11694 | 1.9% |
| Other Income (Expense), net | (4699) | (0.6)% | (1458) | (0.2)% |
| Income Before Taxes on Income | 26361 | 3.1% | 10236 | 1.7% |
| Provision for Income Taxes | 6132 | 0.7% | 2559 | 0.4% |
| Net Income | $20229 | 2.4% | $7677 | 1.3% |
| Earnings Per Share of Common Stock: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.81 |  | $0.30 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.81 |  | $0.30 |  |
| Average Number of Shares Outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic | 24854 |  | 25201 |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted | 24985 |  | 25283 |  |

---

------

---

| | | |
|:---|:---|:---|
| **Condensed Consolidated Statements of Cash Flows** | **Six Months Ended** | **Six Months Ended** |
| (Unaudited) | **December 31,** | **December 31,** |
| (Amounts in Thousands) | **2022** | **2021** |
| Net Cash Flow used for Operating Activities | $(71921) | $(56463) |
| Net Cash Flow used for Investing Activities | (41886) | (27805) |
| Net Cash Flow provided by Financing Activities | 91435 | 35465 |
| Effect of Exchange Rate Change on Cash and Cash Equivalents | (593) | (901) |
| Net Decrease in Cash, Cash Equivalents, and Restricted Cash | (22965) | (49704) |
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | 49851 | 106442 |
| Cash, Cash Equivalents, and Restricted Cash at End of Period | $26886 | $56738 |

---

---

| | | |
|:---|:---|:---|
| | (Unaudited) | |
| **Condensed Consolidated Balance Sheets** | **December 31,<br>2022** | **June 30,<br>2022** |
| (Amounts in Thousands) | **December 31,<br>2022** | **June 30,<br>2022** |
| **ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $26251 | $49851 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivables, net | 265153 | 222857 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract assets | 74861 | 64080 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 487527 | 395630 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 34505 | 28665 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and Equipment, net | 238862 | 206835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 12011 | 12011 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Intangible Assets, net | 13882 | 14707 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets | 42265 | 41131 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets | $1195317 | $1035767 |
| **LIABILITIES AND SHARE OWNERS**' **EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of borrowings under credit facilities | $38534 | $35580 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 337733 | 308617 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 76495 | 64545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt under credit facilities, less current portion | 235000 | 145000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term income taxes payable | 5859 | 7812 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other long-term liabilities | 20548 | 20242 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share Owners' Equity | 481148 | 453971 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities and Share Owners' Equity | $1195317 | $1035767 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reconciliation of Non-GAAP Financial Measures** | **Reconciliation of Non-GAAP Financial Measures** | | | |
| (Unaudited) |  |  |  |  |
| (Amounts in Thousands, except Per Share Data) |  |  |  |  |
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Operating Income, as reported | $17489 | $6914 | $31060 | $11694 |
| SERP | 340 | 402 | 105 | 315 |
| Legal Settlements (Recovery) |  |  |  | (1384) |
| Adjusted Operating Income | $17829 | $7316 | $31165 | $10625 |
| Net Income, as reported | $10720 | $5113 | $20229 | $7677 |
| Adjustments After Measurement Period on GES Acquisition | 279 |  | 279 |  |
| Legal Settlements (Recovery), After-Tax |  |  |  | (1050) |
| Adjusted Net Income | $10999 | $5113 | $20508 | $6627 |
| Diluted Earnings per Share, as reported | $0.43 | $0.20 | $0.81 | $0.30 |
| Adjustments After Measurement Period on GES Acquisition | 0.01 |  | 0.01 |  |
| Legal Settlements (Recovery) |  |  |  | (0.04) |
| Adjusted Diluted Earnings per Share | $0.44 | $0.20 | $0.82 | $0.26 |
|  |  |  | **Twelve Months Ended** | **Twelve Months Ended** |
|  |  |  | **December 31,** | **December 31,** |
|  |  |  | **2022** | **2021** |
| Operating Income |  |  | $71915 | $43411 |
| SERP |  |  | (1773) | 1027 |
| Legal Recovery |  |  |  | (1415) |
| Adjusted Operating Income (non-GAAP) |  |  | $70142 | $43023 |
| Tax Effect |  |  | 18856 | 9530 |
| After-tax Adjusted Operating Income |  |  | $51286 | $33493 |
| Average Invested Capital <sup>(1)</sup> |  |  | $605772 | $424854 |
| ROIC |  |  | 8.5% | 7.9% |

---

*(1) Average invested capital is computed using Share Owners' equity plus current and non-current debt less cash and cash equivalents averaged for the last five quarters.*

<br>